Implication of adenylyl cyclase 8 in pathological smooth muscle cell migration occurring in rat and human vascular remodelling

Journal of Pathology

Volumn 221, Issue 3, 2010, Pages 331-342

  Gueguen, Marie ^a   Keuylian, Zela ^a   Mateo, Véronique ^a   Mougenot, Nathalie ^a   Lompré, Anne Marie ^a   Michel, Jean Baptiste ^b   Meilhac, Olivier ^b   Lipskaia, Larissa ^c   Limon, Isabelle ^a  

^a SORBONNE UNIVERSITÉ   (France)

^b UNIVERSITÉ PARIS DESCARTES   (France)

^c MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

Adenylyl cyclase type 8; Atherosclerosis; Restenosis; Vascular smooth muscle cells

Indexed keywords

ADENYLATE CYCLASE; ADENYLYL CYCLASE 8; GELATINASE A; GELATINASE B; INTERLEUKIN 1BETA; MITOMYCIN; UNCLASSIFIED DRUG;

ADULT; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTERIAL WALL THICKNESS; ARTICLE; CELL MIGRATION; CELL PROLIFERATION; CONTROLLED STUDY; CORONARY ARTERY ATHEROSCLEROSIS; HUMAN; HUMAN CELL; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN SECRETION; RAT; SMOOTH MUSCLE FIBER; UPREGULATION; VASCULAR SMOOTH MUSCLE;

ADENYLATE CYCLASE; ANIMALS; ATHEROSCLEROSIS; CAROTID ARTERY INJURIES; CELL MOVEMENT; CELL PROLIFERATION; CELLS, CULTURED; HUMANS; INTERLEUKIN-1BETA; MALE; MATRIX METALLOPROTEINASE 2; MATRIX METALLOPROTEINASE 9; MIDDLE AGED; MUSCLE, SMOOTH, VASCULAR; MYOCYTES, SMOOTH MUSCLE; RATS; RATS, WISTAR; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, SMALL INTERFERING;

EID: 77953520513     PISSN: 00223417     EISSN: 10969896     Source Type: Journal    
DOI: 10.1002/path.2716     Document Type: Article

References (40)

1. Tedgui A, Mallat W. Cytokines in atherosclerosis: pathogenic and regulatory pathways. Physiol Rev 2006; 86: 515-581.
2. Campbell JH, Campbell GR. Cell biology of atherosclerosis. J Hypertens Suppl 1994; 12: S129-132.
3. Gros R, Ding Q, Chorazyczewski J, Pickering JG, Limbird LE, Feldman RD. Adenylyl cyclase isoform-selective regulation of vascular smooth muscle proliferation and cytoskeletal reorganization. Circ Res 2006; 99: 845-852. (Pubitemid 44556383)
4. Marjamaki A, Sato M, Bouet-Alard R, Yang Q, Limon-Boulez I, Legrand C, et al . Factors determining the specificity of signal transduction by guanine nucleotide-binding protein-coupled receptors. Integration of stimulatory and inhibitory input to the effector adenylyl cyclase. J Biol Chem 1997; 272: 16466-16473. (Pubitemid 27276473)
5. Webb JG, Yates PW, Yang Q, Mukhin YV, Lanier SM. Adenylyl cyclase isoforms and signal integration in models of vascular smooth muscle cells. Am J Physiol Heart Circ Physiol 2001; 281: H1545-1552.
6. Sunahara RK, Taussig R. Isoforms of mammalian adenylyl cyclase: multiplicities of signaling. Mol Interv 2002; 2: 168-184.
7. Clement N, Glorian M, Raymondjean M, Andreani M, Limon I. PGE2 amplifies the effects of IL-1β on vascular smooth muscle cell dedifferentiation: a consequence of the versatility of PGE2 receptors 3 due to the emerging expression of adenylyl cyclase 8. J Cell Physiol 2006; 208: 495-505. (Pubitemid 44141874)
8. Mallat Z, Steg PG, Benessiano J, Tanguy ML, Fox KA, Collet JP, et al . Circulating secretory phospholipase A2 activity predicts recurrent events in patients with severe acute coronary syndromes. J Am Coll Cardiol 2005; 46: 1249-1257.
9. 2+/calmodulin-stimulated enzyme expressed in discrete regions of rat brain. J Biol Chem 1994; 269: 12190-12195.
10. Clement N, Gueguen M, Glorian M, Blaise R, Andreani M, Brou C, et al . Notch3 and IL-1β exert opposing effects on a vascular smooth muscle cell inflammatory pathway in which NF-κB drives crosstalk. J Cell Sci 2007; 120: 3352-3361. (Pubitemid 350028343)
11. Delbosc S, Glorian M, Le Port AS, Bereziat G, Andreani M, Limon I. The benefit of docosahexanoic acid on the migration of vascular smooth muscle cells is partially dependent on Notch regulation of MMP-2/9. Am J Pathol 2008; 172: 1430-1440. (Pubitemid 351671555)
12. Owens GK. Regulation of differentiation of vascular smooth muscle cells. Physiol Rev 1995; 75: 487-517.
13. 2+-ATPase gene transfer reduces vascular smooth muscle cell proliferation and neointima formation in the rat. Circ Res 2005; 97: 488-495.
14. Galis ZS, Khatri JJ. Matrix metalloproteinases in vascular remodeling and atherogenesis: the good, the bad, and the ugly. Circ Res 2002; 90: 251-262.
15. Guenifi A, Portela-Gomes GM, Grimelius L, Efendic S, Abdel- Halim SM. Adenylyl cyclase isoform expression in non-diabetic and diabetic Goto-Kakizaki (GK) rat pancreas. Evidence for distinct overexpression of type-8 adenylyl cyclase in diabetic GK rat islets. Histochem Cell Biol 2000; 113: 81-89. (Pubitemid 30164413)
16. Ramcharitar S, Gaster AL, Daemen J, Serruys P. Drug-eluting stents, restenosis and revascularization. Herz 2007; 32: 287-295.
17. Indolfi C, Di Lorenzo E, Rapacciuolo A, Stingone AM, Stabile E, Leccia A, et al . 8-Chloro-cAMP inhibits smooth muscle cell proliferation in vitro and neointima formation induced by balloon injury in vivo. J Am Coll Cardiol 2000; 36: 288-293. (Pubitemid 30466147)
18. Kamiya K, Sakakibara K, Ryer EJ, Hom RP, Leof EB, Kent KC, et al . Phosphorylation of the cyclic AMP response element binding protein mediates transforming growth factor-β-induced downregulation of cyclin A in vascular smooth muscle cells. Mol Cell Biol 2007; 27: 3489-3498.
19. Sassi Y, Lipskaia L, Vandecasteele G, Nikolaev VO, Hatem SN, Cohen Aubart F, et al . Multidrug resistance-associated protein 4 regulates cAMP-dependent signaling pathways and controls human and rat SMC proliferation. J Clin Invest 2008; 118: 2747-2757.
20. Funakoshi Y, Ichiki T, Takeda K, Tokuno T, Iino N, Takeshita A. Critical role of cAMP-response element-binding protein for angiotensin II-induced hypertrophy of vascular smooth muscle cells. J Biol Chem 2002; 277: 18710-18717.
21. Tokunou T, Ichiki T, Takeda K, Funakoshi Y, Iino N, Takeshita A. cAMP response element-binding protein mediates thrombin-induced proliferation of vascular smooth muscle cells. Arterioscler Thromb Vasc Biol 2001; 21: 1764-1769.
22. Wang AB, Li HL, Zhang R, She ZG, Chen HZ, Huang Y, et al . A20 attenuates vascular smooth muscle cell proliferation and migration through blocking PI3k/Akt singling in vitro and in vivo. J Biomed Sci 2007; 14: 357-371.
23. Dodge-Kafka KL, Kapiloff MS. The mAKAP signaling complex: integration of cAMP, calcium, and MAP kinase signaling pathways. Eur J Cell Biol 2006; 85: 593-602.
24. Georget M, Mateo P, Vandecasteele G, Lipskaia L, Defer N, Hanoune J, et al . Cyclic AMP compartmentation due to increased cAMP-phosphodiesterase activity in transgenic mice with a cardiac-directed expression of the human adenylyl cyclase type 8 (AC8). FASEB J 2003; 17: 1380-1391.
25. Smith KE, Gu C, Fagan KA, Hu B, Cooper DM. Residence of adenylyl cyclase type 8 in caveolae is necessary but not sufficient for regulation by capacitative Ca2+ entry. J Biol Chem 2002; 277: 6025-6031. (Pubitemid 34968386)
26. 2+-sensitive adenylyl cyclases dictate their targeting to plasma membrane lipid rafts. J Biol Chem 2005; 280: 6380-6391.
27. Wadzinski BE, Wheat WH, Jaspers S, Peruski LF Jr, Lickteig RL, Johnson GL, Klemm DJ. Nuclear protein phosphatase 2A dephosphorylates protein kinase A-phosphorylated CREB and regulates CREB transcriptional stimulation. Mol Cell Biol 1993; 13: 2822-2834. (Pubitemid 23133954)
28. Hong K, Lou L, Gupta S, Ribeiro-Neto F, Altschuler DL. A novel Epac-Rap-PP2A signaling module controls cAMP-dependent Akt regulation. J Biol Chem 2008; 283: 23129-23138.
29. Yokoyama U, Minamisawa S, Quan H, Akaike T, Jin M, Otsu K, et al . Epac1 is upregulated during neointima formation and promotes vascular smooth muscle cell migration. Am J Physiol Heart Circ Physiol 2008; 295: H1547-1555.
30. Yokoyama U, Minamisawa S, Quan H, Akaike T, Suzuki S, Jin M, et al . Prostaglandin E2-activated Epac promotes neointimal formation of the rat ductus arteriosus by a process distinct from that of cAMP-dependent protein kinase A. J Biol Chem 2008; 283: 28702-28709.
31. Huston E, Lynch MJ, Mohamed A, Collins DM, Hill EV, MacLeod R, et al . EPAC and PKA allow cAMP dual control over DNA-PK nuclear translocation. Proc Natl Acad Sci USA 2008; 105: 12791-12796.
32. Raymond DR, Wilson LS, Carter RL, Maurice DH. Numerous distinct PKA-, or EPAC-based, signalling complexes allow selective phosphodiesterase 3 and phosphodiesterase 4 coordination of cell adhesion. Cell Signal 2007; 19: 2507-2518.
33. Wei J, Wayman G, Storm DR. Phosphorylation and inhibition of type III adenylyl cyclase by calmodulin-dependent protein kinase II in vivo. J Biol Chem 1996; 271: 24231-24235. (Pubitemid 26327410)
34. Guillou JL, Nakata H, Cooper DM. Inhibition by calcium of mammalian adenylyl cyclases. J Biol Chem 1999; 274: 35539-35545. (Pubitemid 129512849)
35. 2+- inhibitable adenylyl cyclase from NCB-20 cells. Proc Natl Acad Sci USA 1992; 89: 6716-6720.
36. 2- induced growth inhibition in arterial smooth muscle cells. J Biol Chem 2001; 276: 34206-34212.
37. House SJ, Ginnan RG, Armstrong SE, Singer HA. Calcium/calmodulin- dependent protein kinase II-δ isoform regulation of vascular smooth muscle cell proliferation. Am J Physiol Cell Physiol 2007; 292: C2276-2287.
38. Mercure MZ, Ginnan R, Singer HA. CaM kinase II-δ2-dependent regulation of vascular smooth muscle cell polarization and migration. Am J Physiol Cell Physiol 2008; 294: C1465-1475.
39. Schaefer ML, Wong ST, Wozniak DF, Muglia LM, Liauw JA, Zhuo M, et al . Altered stress-induced anxiety in adenylyl cyclase type VIII-deficient mice. J Neurosci 2000; 20: 4809-4820. (Pubitemid 30421684)
40. Fantidis P. The role of intracellular 3′,5′-cyclic adenosine monophosphate (cAMP) in atherosclerosis. Curr Vasc Pharmacol 2010; [1 January; Epub ahead of print].